Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Non-colorectal liver metastases: surgical treatment options

Vladislav Treska, Vaclav Liska, Tomas Skalicky, Alan Sutnar, Inka Treskova, Andrea Narsanska, Monika Vachtova,

. 2012 ; 59 (113) : 245-248.

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12024112

Grantová podpora
NS10240 MZ0 CEP - Centrální evidence projektů
NS9727 MZ0 CEP - Centrální evidence projektů

BACKGROUND/AIMS: Due to different biological characteristics of non-colorectal liver metastasizes (NCLM), surgical treatment, especially it´s long term results, is a topic of discussion. The aim of the study was to evaluate the single center experience with surgical treatment of NCLM. METHODOLOGY: Seventy two patients were prospectively included. The average length of time after the primary surgery was 3.9 years (0-8.5 years). RFA prevailed -50 patients (69.4%), resection presenting 30.6%. Preoperative chemotherapeutical downstaging or portal vein embolization was performed on 12 patients (16.7%). Resectable or radiofrequency ablation (RFA) treatable extrahepatic metastasizes were removed in 26 patients (36.1%). RESULTS: One, three and five years patient survival after the liver resection or RFA was 88.6, 72.5 and 36.9%. The best survival rate was in patients with carcinoid (5 years-100%), breast cancer (5 years-33.8%), renal carcinoma (3 years-44.4% ) and gynecological tumors metastasizes (2 years-72.9%). With regards to long-term survival of patients, we did not find any statistically significant difference between RFA and resection. Patients with extrahepatic metastasizes had worse prognosis (p<0.01). CONCLUSIONS: Liver resection and RFA in NCLM have an unambiguous place in multi-modal curative strategy. The decision for surgical treatment of patients suffering from NCLM, is strictly individual with the aim of achieving qualitative long-term survival.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12024112
003      
CZ-PrNML
005      
20140901162127.0
007      
ta
008      
120815s2012 gr f 000 0eng||
009      
AR
024    7_
$a 10.5754/hge10292 $2 doi
035    __
$a (PubMed)22251545
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Treska, Vladislav $u Department of Surgery, School of Medicine, Plxen, Czech Republic. treska@fnplzen.cz
245    10
$a Non-colorectal liver metastases: surgical treatment options / $c Vladislav Treska, Vaclav Liska, Tomas Skalicky, Alan Sutnar, Inka Treskova, Andrea Narsanska, Monika Vachtova,
520    9_
$a BACKGROUND/AIMS: Due to different biological characteristics of non-colorectal liver metastasizes (NCLM), surgical treatment, especially it´s long term results, is a topic of discussion. The aim of the study was to evaluate the single center experience with surgical treatment of NCLM. METHODOLOGY: Seventy two patients were prospectively included. The average length of time after the primary surgery was 3.9 years (0-8.5 years). RFA prevailed -50 patients (69.4%), resection presenting 30.6%. Preoperative chemotherapeutical downstaging or portal vein embolization was performed on 12 patients (16.7%). Resectable or radiofrequency ablation (RFA) treatable extrahepatic metastasizes were removed in 26 patients (36.1%). RESULTS: One, three and five years patient survival after the liver resection or RFA was 88.6, 72.5 and 36.9%. The best survival rate was in patients with carcinoid (5 years-100%), breast cancer (5 years-33.8%), renal carcinoma (3 years-44.4% ) and gynecological tumors metastasizes (2 years-72.9%). With regards to long-term survival of patients, we did not find any statistically significant difference between RFA and resection. Patients with extrahepatic metastasizes had worse prognosis (p<0.01). CONCLUSIONS: Liver resection and RFA in NCLM have an unambiguous place in multi-modal curative strategy. The decision for surgical treatment of patients suffering from NCLM, is strictly individual with the aim of achieving qualitative long-term survival.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a katetrizační ablace $x škodlivé účinky $x mortalita $7 D017115
650    _2
$a adjuvantní chemoterapie $7 D017024
650    _2
$a terapeutická embolizace $7 D004621
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hepatektomie $x škodlivé účinky $x mortalita $7 D006498
650    _2
$a lidé $7 D006801
650    _2
$a nádory jater $x mortalita $x sekundární $x chirurgie $7 D008113
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a metastázektomie $x škodlivé účinky $x mortalita $7 D059146
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neoadjuvantní terapie $7 D020360
650    _2
$a výběr pacientů $7 D018579
650    _2
$a prospektivní studie $7 D011446
650    _2
$a analýza přežití $7 D016019
650    _2
$a míra přežití $7 D015996
650    _2
$a přežívající $x statistika a číselné údaje $7 D017741
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Liska, Vaclav $u Department of Surgery, School of Medicine, Plxen, Czech Republic
700    1_
$a Skalicky, Tomas $u Department of Surgery, School of Medicine, Plxen, Czech Republic
700    1_
$a Sutnar, Alan $u Department of Surgery, School of Medicine, Plxen, Czech Republic
700    1_
$a Treskova, Inka $u Department of Surgery, School of Medicine, Plxen, Czech Republic
700    1_
$a Narsanska, Andrea $u Department of Surgery, School of Medicine, Plxen, Czech Republic
700    1_
$a Vachtova, Monika $u Department of Surgery, School of Medicine, Plxen, Czech Republic
773    0_
$w MED00002025 $t Hepato-gastroenterology $x 0172-6390 $g Roč. 59, č. 113 (2012), s. 245-248
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22251545 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120815 $b ABA008
991    __
$a 20140901162517 $b ABA008
999    __
$a ok $b bmc $g 946260 $s 781440
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 59 $c 113 $d 245-248 $i 0172-6390 $m Hepato-gastroenterology $n Hepatogastroenterology $x MED00002025
GRA    __
$a NS10240 $p MZ0
GRA    __
$a NS9727 $p MZ0
LZP    __
$a Pubmed-20120815/12/02

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...